ewopharma: Suche

1. Über Ewopharma

… UNSERE STRATEGIE GEBIET UNSERE WERTE UNTERNEHMENS- VERANTWORTUNG VISION/MISSION FÜHRUNG Über Ewopharma Ewopharma ist das Nachfolgeunternehmen zu M.R. Leclerc & Co., gegründet 1959. Von Anfang an lag unser…

2. Ewopharma lanciert das neue Erscheinungsbild

… Schaffhausen, 12.04.19 – Anlässlich des 60-jährigen Firmenjubiläums im 2019 gibt sich Ewopharma ein neues Erscheinungsbild. Die Anpassungen sind eine behutsame, zeitgemässe Weiterentwicklung – eine Evolution, keine…

3. Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

… Schaffhausen, Switzerland, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of…

4. Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

… diseases, today announced it has signed an exclusive distribution agreement with Switzerland-based Ewopharma for Piclidenoson in the treatment of psoriasis and Namodenoson in the treatment of liver diseases…

5. Amikin® - Ewopharma übernimmt den Vertrieb eines unentbehrlichen Antibiotikums in der Schweiz

… Schaffhausen, 29 Juli 2019 – Ewopharma und Vianex S.A. freuen sich, ihre neue Partnerschaft für den Vertrieb von Amikin® (Amikacin) in der Schweiz bekannt zu geben. Ewopharma wird ab dem 12. August 2019 die neue…

6. Ewopharma strengthens its oncology business

… Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st…

7. Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

… someone else. To learn more please check: www.proibs.eu. Calmino group AB (Gothenburg, Sweden) and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the…

8. Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)

… SCHAFFHAUSEN, SWITZERLAND and HATFIELD, UK, 26th March, 2020 – Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pharmaceutical company are pleased to…

9. Shield Therapeutics and ewopharma sign Feraccru licence agreement for Switzerland

… Therapeutics plc (LSE:STX), a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical marketing company headquartered in Schaffhausen, Switzerland, are pleased to…

10. Otsuka and Ewopharma join the fight against tuberculosis in Romania by launching Deltyba®

… Otsuka and Ewopharma AG join the fight against tuberculosis in Romania by launching Otsuka’s orphan drug Deltyba® (delamanid) for multidrug-resistant tuberculosis SCHAFFHAUSEN, 20th January 2020 - Tuberculosis…